Atlas Trials

A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168

Clinical trial NCT05988021 · COMPLETED

Trial details

NCT number
NCT05988021
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Start date
2015-12-03
Primary completion
2016-02-09
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.